FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and represents a pharmaceutical composition in form of nasal spray, having analgesic and anti-inflammatory activity, characterized by the fact that it comprises tromethamine ketorolac as an active substance and additives: phenoxyethanol as a antimicrobial preserving agent and antiseptic, poloxamer 407 as a humidifier, disodium edetate as a chelating agent, sodium hydroxide and potassium dihydrogen phosphate as a buffer mixture and a pH regulator and water for injections, wherein ingredients of composition are taken in certain ratio, wt%.
EFFECT: invention ensures increased storage life after primary opening up to 20 days, in conditions of a refrigerating chamber, and at room temperature, wider range of nasal sprays, having analgesic and anti-inflammatory activity, as well as storage life of 2 years.
2 cl, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION IN FORM OF NALOXONE HYDROCHLORIDE-BASED NASAL SPRAY AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2572217C2 |
ANTIVIRAL AGENT IN LIQUID FORM AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2768656C1 |
KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATMENT OR PREVENTION OF OCULAR PAIN | 2009 |
|
RU2431469C1 |
LINEZOLID COMPOSITIONS | 2018 |
|
RU2771279C2 |
COMPOSITIONS AND METHODS OF TREATING OPIOID OVERDOSE | 2017 |
|
RU2769397C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2642624C2 |
PARENTERAL DRUG PREPARATION OF RIFABUTIN FOR THERAPY OF HUMAN AND ANIMAL INFECTIOUS DISEASES | 2012 |
|
RU2481109C1 |
COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE | 2017 |
|
RU2767062C2 |
EYE DROPS | 2010 |
|
RU2453304C2 |
STABLE PHARMACEUTICAL COMPOSITION WITH FIXED DOSE, CONTAINING MOMETASONE AND OLOPATADINE | 2014 |
|
RU2687551C2 |
Authors
Dates
2017-02-28—Published
2015-11-18—Filed